BIOPHARMA DEVELOPMENT AI BY BCG X Trademark

Trademark Overview

On Monday, December 23, 2024, a trademark application was filed for BIOPHARMA DEVELOPMENT AI BY BCG X with the United States Patent and Trademark Office. The USPTO has given the BIOPHARMA DEVELOPMENT AI BY BCG X trademark a serial number of 98919023. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 22, 2025. This trademark is owned by The Boston Consulting Group, Inc.. The BIOPHARMA DEVELOPMENT AI BY BCG X trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; consulting services regarding cost containment in the field of clinical trials

Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, optimizing resource utilization, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials; consulting services for others in the field of ...
biopharma development ai by bcg x

General Information

Serial Number98919023
Word MarkBIOPHARMA DEVELOPMENT AI BY BCG X
Filing DateMonday, December 23, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 22, 2025

Trademark Statements

Description of MarkThe mark consists of the stacked words "BIOPHARMA , above "DEVELOPMENT AI", which is, in turn, above "BY BCG X", all to the right of a box design containing a circle and two arcs.
Pseudo MarkBIOPHARMA DEVELOPMENT AI BY BOSTON CONSULTING GROUP X
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; consulting services regarding cost containment in the field of clinical trials
NOT AVAILABLEBIOPHARMA DEVELOPMENT AI
Goods and ServicesProviding temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, optimizing resource utilization, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 23, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 23, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThe Boston Consulting Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameThe Boston Consulting Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, December 23, 2024NEW APPLICATION ENTERED
Friday, May 9, 2025ASSIGNED TO EXAMINER
Sunday, January 12, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, January 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 15, 2025NON-FINAL ACTION WRITTEN
Tuesday, June 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 15, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 16, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 22, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 22, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

development biopharma clinical management trials field providing consulting business temporary software services